C-reactive protein in patients with acute heart failure and preserved ejection fraction

被引：0
|
作者：
Villar, Sandra [1 ]
Mollar, Anna [1 ,2 ]
Lorenzo, Miguel [1 ]
Nunez, Gonzalo [1 ]
de la Espriella, Rafael [1 ]
Nunez, Julio [1 ,2 ]
机构：
[1] Univ Valencia, Hosp Clin Univ Valencia, Serv Cardiol, Inst Invest Sanit INCLIVA, Valencia, Spain
[2] Ctr Invest Biomed Red Enfermedades Cardiovasc CIBE, Valencia, Spain
来源：
REVISTA ESPANOLA DE CARDIOLOGIA | 2024年 / 77卷 / 05期
关键词：
D O I：
10.1016/j.recesp.2023.11.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：430 / 433
页数：4
相关论文
共 50 条
  • [11] Diagnostic and prognostic value of serum C-reactive protein in heart failure with preserved ejection fraction: a systematic review and meta-analysis
    Lakhani, Ishan
    Wong, Michelle Vangi
    Hung, Joshua Kai Fung
    Gong, Mengqi
    Waleed, Khalid Bin
    Xia, Yunlong
    Lee, Sharen
    Roever, Leonardo
    Liu, Tong
    Tse, Gary
    Leung, Keith Sai Kit
    Li, Ka Hou Christien
    HEART FAILURE REVIEWS, 2021, 26 (05) : 1141 - 1150
  • [12] Changes in C-reactive Protein (CRP) in Patients with Acute Heart Failure
    Kuragaichi, Takashi
    Sato, Yukihito
    Koyama, Satoshi
    Inazumi, Hideaki
    Shinomiya, Haruki
    Fujiwara, Hisayoshi
    Takatsu, Yoshiki
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (10) : S173 - S173
  • [13] C-reactive protein predicts mortality in patients with acute heart failure
    Chae, CU
    Lloyd-Jones, DM
    Dec, GW
    Stevenson, LW
    Ridker, PM
    Januzzi, JL
    CIRCULATION, 2006, 113 (08) : E336 - E336
  • [14] Evaluation of high sensitivity C-reactive protein in vericiguat-treated patients with heart failure with reduced ejection fraction
    Kramer, F.
    Voss, S.
    Igl, B-W
    Butler, J.
    Lam, C. S. P.
    Maggioni, A. P.
    Roessig, L.
    Shah, S. J.
    Spertus, J. A.
    Pieske, B.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 261 - 261
  • [15] HEART FAILURE IN PATIENTS WITH PRESERVED EJECTION FRACTION - PUMPING HEART FAILURE?
    Sokolov, A. A.
    Martsinkevich, G., I
    KARDIOLOGIYA, 2018, 58 (06) : 79 - 84
  • [16] Spironolactone in patients with heart failure and preserved ejection fraction
    Sanchez-Sanchez, C.
    Mendoza-Ruiz de Zuazu, H. F.
    Formiga, F.
    Manzano, L.
    Ceresuela, L. M.
    Carrera-Izquierdo, M.
    Gonzalez Franco, A.
    Epelde-Gonzalo, F.
    Cerqueiro-Gonzalez, J. M.
    Montero-Perez-Barquero, M.
    REVISTA CLINICA ESPANOLA, 2015, 215 (06): : 301 - 307
  • [17] Hospitalisation in Patients With Heart Failure With Preserved Ejection Fraction
    Nanayakkara, Shane
    Patel, Hitesh C.
    Kaye, David M.
    CLINICAL MEDICINE INSIGHTS-CARDIOLOGY, 2018, 12
  • [18] Treatment of patients with heart failure and preserved ejection fraction
    Deswal A.
    Bozkurt B.
    Current Treatment Options in Cardiovascular Medicine, 2008, 10 (6) : 516 - 528
  • [19] Outcomes in Patients with Heart Failure with Preserved Ejection Fraction
    Poppe, Katrina K.
    Doughty, Robert N.
    HEART FAILURE CLINICS, 2014, 10 (03) : 503 - +
  • [20] Irbesartan in patients with heart failure and preserved ejection fraction
    Forman D.
    Gaziano J.M.
    Current Cardiovascular Risk Reports, 2009, 3 (5) : 311 - 312
12345